Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines.

Identifieur interne : 003D50 ( Main/Exploration ); précédent : 003D49; suivant : 003D51

Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines.

Auteurs : Lanying Du [République populaire de Chine] ; Yuxian He ; Yijia Wang ; Haojie Zhang ; Selene Ma ; Charlotte K L. Wong ; Sharon H W. Wu ; Fai Ng ; Jian-Dong Huang ; Kwok-Yung Yuen ; Shibo Jiang ; Yusen Zhou ; Bo-Jian Zheng

Source :

RBID : pubmed:16793110

Descripteurs français

English descriptors

Abstract

Development of an effective vaccine for severe acute respiratory syndrome (SARS) remains to be a priority to prevent possible re-emergence of SARS coronavirus (SARS-CoV). We previously demonstrated that the receptor-binding domain (RBD) of SARS-CoV S protein is a major target of neutralizing antibodies. This suggests that the RBD may serve as an ideal vaccine candidate. Recombinant adeno-associated virus (rAAV) has been proven to be an effective system for gene delivery and vaccine development. In this study, a novel vaccine against SARS-CoV was developed based on the rAAV delivery system. The gene encoding RBD was cloned into a pAAV-IRES-hrGFP plasmid. The immunogenicity induced by the resulting recombinant RBD-rAAV was evaluated in BALB/c mice. The results demonstrated that (1) a single dose of RBD-rAAV vaccination could induce sufficient neutralizing antibody against SARS-CoV infection; (2) two more repeated doses of the vaccination boosted the neutralizing antibody to about 5 times of the level achieved by a single dose of the immunization and (3) the level of the antibody continued to increase for the entire duration of the experiment of 5.5 months. These results suggested that RBD-rAAV is a promising SARS candidate vaccine.

DOI: 10.1016/j.virol.2006.03.049
PubMed: 16793110


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines.</title>
<author>
<name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR</wicri:regionArea>
<wicri:noRegion>Hong Kong SAR</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="He, Yuxian" sort="He, Yuxian" uniqKey="He Y" first="Yuxian" last="He">Yuxian He</name>
</author>
<author>
<name sortKey="Wang, Yijia" sort="Wang, Yijia" uniqKey="Wang Y" first="Yijia" last="Wang">Yijia Wang</name>
</author>
<author>
<name sortKey="Zhang, Haojie" sort="Zhang, Haojie" uniqKey="Zhang H" first="Haojie" last="Zhang">Haojie Zhang</name>
</author>
<author>
<name sortKey="Ma, Selene" sort="Ma, Selene" uniqKey="Ma S" first="Selene" last="Ma">Selene Ma</name>
</author>
<author>
<name sortKey="Wong, Charlotte K L" sort="Wong, Charlotte K L" uniqKey="Wong C" first="Charlotte K L" last="Wong">Charlotte K L. Wong</name>
</author>
<author>
<name sortKey="Wu, Sharon H W" sort="Wu, Sharon H W" uniqKey="Wu S" first="Sharon H W" last="Wu">Sharon H W. Wu</name>
</author>
<author>
<name sortKey="Ng, Fai" sort="Ng, Fai" uniqKey="Ng F" first="Fai" last="Ng">Fai Ng</name>
</author>
<author>
<name sortKey="Huang, Jian Dong" sort="Huang, Jian Dong" uniqKey="Huang J" first="Jian-Dong" last="Huang">Jian-Dong Huang</name>
</author>
<author>
<name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
</author>
<author>
<name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name>
</author>
<author>
<name sortKey="Zhou, Yusen" sort="Zhou, Yusen" uniqKey="Zhou Y" first="Yusen" last="Zhou">Yusen Zhou</name>
</author>
<author>
<name sortKey="Zheng, Bo Jian" sort="Zheng, Bo Jian" uniqKey="Zheng B" first="Bo-Jian" last="Zheng">Bo-Jian Zheng</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16793110</idno>
<idno type="pmid">16793110</idno>
<idno type="doi">10.1016/j.virol.2006.03.049</idno>
<idno type="wicri:Area/PubMed/Corpus">002196</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002196</idno>
<idno type="wicri:Area/PubMed/Curation">002196</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002196</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002039</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002039</idno>
<idno type="wicri:Area/Ncbi/Merge">001544</idno>
<idno type="wicri:Area/Ncbi/Curation">001544</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001544</idno>
<idno type="wicri:doubleKey">0042-6822:2006:Du L:recombinant:adeno:associated</idno>
<idno type="wicri:Area/Main/Merge">003F23</idno>
<idno type="wicri:Area/Main/Curation">003D50</idno>
<idno type="wicri:Area/Main/Exploration">003D50</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines.</title>
<author>
<name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong SAR</wicri:regionArea>
<wicri:noRegion>Hong Kong SAR</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="He, Yuxian" sort="He, Yuxian" uniqKey="He Y" first="Yuxian" last="He">Yuxian He</name>
</author>
<author>
<name sortKey="Wang, Yijia" sort="Wang, Yijia" uniqKey="Wang Y" first="Yijia" last="Wang">Yijia Wang</name>
</author>
<author>
<name sortKey="Zhang, Haojie" sort="Zhang, Haojie" uniqKey="Zhang H" first="Haojie" last="Zhang">Haojie Zhang</name>
</author>
<author>
<name sortKey="Ma, Selene" sort="Ma, Selene" uniqKey="Ma S" first="Selene" last="Ma">Selene Ma</name>
</author>
<author>
<name sortKey="Wong, Charlotte K L" sort="Wong, Charlotte K L" uniqKey="Wong C" first="Charlotte K L" last="Wong">Charlotte K L. Wong</name>
</author>
<author>
<name sortKey="Wu, Sharon H W" sort="Wu, Sharon H W" uniqKey="Wu S" first="Sharon H W" last="Wu">Sharon H W. Wu</name>
</author>
<author>
<name sortKey="Ng, Fai" sort="Ng, Fai" uniqKey="Ng F" first="Fai" last="Ng">Fai Ng</name>
</author>
<author>
<name sortKey="Huang, Jian Dong" sort="Huang, Jian Dong" uniqKey="Huang J" first="Jian-Dong" last="Huang">Jian-Dong Huang</name>
</author>
<author>
<name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
</author>
<author>
<name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name>
</author>
<author>
<name sortKey="Zhou, Yusen" sort="Zhou, Yusen" uniqKey="Zhou Y" first="Yusen" last="Zhou">Yusen Zhou</name>
</author>
<author>
<name sortKey="Zheng, Bo Jian" sort="Zheng, Bo Jian" uniqKey="Zheng B" first="Bo-Jian" last="Zheng">Bo-Jian Zheng</name>
</author>
</analytic>
<series>
<title level="j">Virology</title>
<idno type="ISSN">0042-6822</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antibodies, Viral (biosynthesis)</term>
<term>Cell Line</term>
<term>Dependovirus (genetics)</term>
<term>Dependovirus (metabolism)</term>
<term>Female</term>
<term>Genetic Vectors</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Neutralization Tests</term>
<term>Protein Structure, Tertiary</term>
<term>Receptors, Virus (metabolism)</term>
<term>Recombinant Proteins (metabolism)</term>
<term>SARS Virus (immunology)</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Anticorps antiviraux (biosynthèse)</term>
<term>Cellules HeLa</term>
<term>Dependovirus (génétique)</term>
<term>Dependovirus (métabolisme)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Protéines recombinantes (métabolisme)</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Structure tertiaire des protéines</term>
<term>Tests de neutralisation</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Vecteurs génétiques</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Dependovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Dependovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Vaccins antiviraux</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>SARS Virus</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Dependovirus</term>
<term>Receptors, Virus</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Dependovirus</term>
<term>Protéines recombinantes</term>
<term>Récepteurs viraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Female</term>
<term>Genetic Vectors</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Neutralization Tests</term>
<term>Protein Structure, Tertiary</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules HeLa</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Structure tertiaire des protéines</term>
<term>Tests de neutralisation</term>
<term>Vecteurs génétiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Development of an effective vaccine for severe acute respiratory syndrome (SARS) remains to be a priority to prevent possible re-emergence of SARS coronavirus (SARS-CoV). We previously demonstrated that the receptor-binding domain (RBD) of SARS-CoV S protein is a major target of neutralizing antibodies. This suggests that the RBD may serve as an ideal vaccine candidate. Recombinant adeno-associated virus (rAAV) has been proven to be an effective system for gene delivery and vaccine development. In this study, a novel vaccine against SARS-CoV was developed based on the rAAV delivery system. The gene encoding RBD was cloned into a pAAV-IRES-hrGFP plasmid. The immunogenicity induced by the resulting recombinant RBD-rAAV was evaluated in BALB/c mice. The results demonstrated that (1) a single dose of RBD-rAAV vaccination could induce sufficient neutralizing antibody against SARS-CoV infection; (2) two more repeated doses of the vaccination boosted the neutralizing antibody to about 5 times of the level achieved by a single dose of the immunization and (3) the level of the antibody continued to increase for the entire duration of the experiment of 5.5 months. These results suggested that RBD-rAAV is a promising SARS candidate vaccine.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="He, Yuxian" sort="He, Yuxian" uniqKey="He Y" first="Yuxian" last="He">Yuxian He</name>
<name sortKey="Huang, Jian Dong" sort="Huang, Jian Dong" uniqKey="Huang J" first="Jian-Dong" last="Huang">Jian-Dong Huang</name>
<name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name>
<name sortKey="Ma, Selene" sort="Ma, Selene" uniqKey="Ma S" first="Selene" last="Ma">Selene Ma</name>
<name sortKey="Ng, Fai" sort="Ng, Fai" uniqKey="Ng F" first="Fai" last="Ng">Fai Ng</name>
<name sortKey="Wang, Yijia" sort="Wang, Yijia" uniqKey="Wang Y" first="Yijia" last="Wang">Yijia Wang</name>
<name sortKey="Wong, Charlotte K L" sort="Wong, Charlotte K L" uniqKey="Wong C" first="Charlotte K L" last="Wong">Charlotte K L. Wong</name>
<name sortKey="Wu, Sharon H W" sort="Wu, Sharon H W" uniqKey="Wu S" first="Sharon H W" last="Wu">Sharon H W. Wu</name>
<name sortKey="Yuen, Kwok Yung" sort="Yuen, Kwok Yung" uniqKey="Yuen K" first="Kwok-Yung" last="Yuen">Kwok-Yung Yuen</name>
<name sortKey="Zhang, Haojie" sort="Zhang, Haojie" uniqKey="Zhang H" first="Haojie" last="Zhang">Haojie Zhang</name>
<name sortKey="Zheng, Bo Jian" sort="Zheng, Bo Jian" uniqKey="Zheng B" first="Bo-Jian" last="Zheng">Bo-Jian Zheng</name>
<name sortKey="Zhou, Yusen" sort="Zhou, Yusen" uniqKey="Zhou Y" first="Yusen" last="Zhou">Yusen Zhou</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D50 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16793110
   |texte=   Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16793110" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021